Drug Center Staff Make Personal Pitch At Makena Hearing

Two FDA drug reviewers highlighted their own family experiences with preterm birth, humanizing the regulators who are pushing to withdraw the only drug currently on the market, and highlighting that desire for treatment shouldn’t necessarily lead to acceptance of inadequate options.